Migraine, the impact of menopause
Migraines affect 1 in 5 women, with three times as many women being affected as men. The symptoms can be really debilitating and include much more than headaches. Triggers There is often a history of migraine in the family, suggesting a genetic susce…
Read MoreFezolinetant (Veoza®), what you need to know about the new non-hormonal treatment for hot flushes.
The new non-hormonal drug for hot flushes and night sweats, Fezolinetant, is part of an entirely new class of drug, the NK3 antagonists. Fezolinetant has now been approved for use in the UK, having been approved for use in the USA since May 2023. Cur…
Read MoreOsteoporosis, the impact of menopause, and holistic strategies for optimising your bone health
In my experience, bone health is not something many people are that concerned by, unless they have seen first hand how significantly osteoporosis has affected a family member. However, the implications of falls and fractures, especially for postmenop…
Read More